‘These drugs will not be manufactured’
Health experts claimed that the Food and Drug Administration had “fully approved” the Pfizer Inc.-BioNTech COVID-19 shots called Comirnaty.
But the drug company now has revealed they simply won’t be available.
The company has updated the Centers for Disease Control website with that detail.
“As Liberty Counsel has stated from the beginning, there is no FDA approved COVID shot available. All COVID shots are under Emergency Use Authorization (EUA), which means people have the right to refuse them,” the legal team explained.
Pfizer now states: “Pfizer received initial FDA BLA license on 8/23/2021 for its COVID-19 vaccine for use in individuals 16 and older (COMIRNATY). At that time, the FDA published a BLA package insert that included the approved new COVID-19 vaccine tradename COMIRNATY and listed 2 new NDCs (0069-1000-03, 0069-1000-02) and images of labels with the new tradename. These NDCs will not be manufactured. Only NDCs for the subsequently BLA approved tris-sucrose formulation will be produced.”
That means any Pfizer COVID-19 shot has been for emergency use, and experimental.
“In fact, the FDA previously did a bait and switch by announcing it approved its ‘first COVID-19 vaccine’ in order to push the ‘vaccine’ mandates and protect the Pfizer pharmaceutical company from legal liability. The FDA took just 108 days to review the data before granting the Pfizer-BioNTech COVID-19 shot full approval. The Pfizer injection, on the other hand, is still considered experimental under U.S. law,” Liberty Counsel explained.
“Instead of admitting this tactic of not intentionally supplying the ‘FDA approved’ Comirnaty, Pfizer labeled this as an inventory issue and previously put this statement on the CDC website: ‘Pfizer received FDA BLA license on 8/23/2021 for its COVID-19 vaccine for use in individuals 16 and older (COMIRNATY). At that time, the FDA published a BLA package insert that included the approved new COVID-19 vaccine tradename COMIRNATY and listed 2 new NDCs (0069-1000-03, 0069-1000-02) and images of labels with the new tradename. At present, Pfizer does not plan to produce any product with these new NDCs and labels over the next few months while EUA authorized product is still available and being made available for U.S. distribution. As such, the CDC, AMA, and drug compendia may not publish these new codes until Pfizer has determined when the product will be produced with the BLA labels.'”
The FDA had provided a “deceptive” approval letter to the company about Comirnaty, and then said in another letter they still are under Emergency Use Authorization.
The effect was to “mislead the public in order to push the agenda ‘to get shots in every arm’ through unlawful mandates,” Liberty Counsel said.
“Pfizer never intended to produce a fully approved version of its shot. It was simply a manipulative scheme to deceive people into thinking they had no right to invoke the Emergency Use Authorization law to decline the shots. Now many people have lost their jobs, their health, and some even their lives, as a result of this deception,” charged Liberty Counsel chief Mat Staver.